Chewy Inc Q2 2020 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst : Just curious if you could touch on the behavior you're seeing with the pharmacy customers, if there's anything different as far as attachment rate. And then also, as you look to the back half, kind of keeping the -- at least the earnings guidance relatively in line on higher sales, if that's just maintaining some sort of conservatism just given the visibility or if you're seeing kind of incrementally higher costs or reason to be cautious?

Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst : Just curious on the hard goods, the total growth in that category is 52%. What drove that acceleration? And am I right in that the private label hard goods is actually in the other line item? And if so, kind of if you're seeing private label hard goods grow ahead of that? And is that having sort of a benefit for the hard goods category more broadly?

Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst : Yes. No, I was just curious, I guess I am right that the private label hard goods is embedded in the other category. So I guess I was just curious if the -- you called out private label hard goods, I think, in the gross margin comments. It would stand to reason that you're seeing private label hard goods maybe grow ahead of your third-party hard goods and if there's some benefit there, I guess, in the broader hard goods category growth.

Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst : And 15% is total...

Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst : Mario, yes. Sorry.

Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst : Okay. I just have some bad numbers perhaps.